7th Annual Peptides and Oligonucleotides Congress

Start Date : April 27, 2020
End Date : April 29, 2020
Time : 8:00 am to5:00 pm

Phone : +44 1865 248455
Email : b.copeman@oxfordglobal.co.uk

Location :
Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith, London, W6 8DR, United Kingdom


Get Direction View Large Map


Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery and development of oligonucleotide therapeutics, manufacturing and process development.


View Agenda: https://bit.ly/2PP4A5V


27 April 2019 – Day One (Kick-off Session)

• Turning Challenges to Successes in Peptides Delivery and Formulation


28 April 2020 – Day Two

• Peptide Design, Synthesis, Purification and Analytical Technologies

• Peptide Manufacturing and Process Development

• Oligonucleotide Synthesis, Chemistry, Formulation and Delivery, Process and Analytical Development


29 April 2020 – Day Three

• Peptide Therapeutics: Case Studies, Immunogenicity and Novel Disease Treatments

• Oligonucleotide Therapeutics and Manufacturing


2020 Live Webinar

Targeted, Controlled and Responsive Therapeutic Delivery through the Design of Self-Assembling Peptide Hydrogels

Presented by Aline Miller, Professor, University of Manchester

Tuesday 14th January 2020 | 02:00 PM GMT

Register: https://bit.ly/2pzwpV9



LinkedIn: https://go.evvnt.com/546653-3?pid=3506


Speakers: Gene Liau, Executive Vice President and Head, Research and Preclinical Development, Stoke Therapeutics, Ekkehard Leberer, Senior Director, Sanofi, Matthew Catley, Research Director, MiNA Therapeutics, Jennifer Franklin, Director, CMC Regulatory Affairs, IONIS Pharmaceuticals, Michael Agrez, Chief Executive Officer, InterK Peptide Therapeutics, David Earp, President and Chief Executive Officer, Circle Pharma, Ali Tavassoli, Founder and Chief Scientific Officer, Curve Therapeutics, Olivier Kitten, Founder and Chief Executive Officer, Affilogic, Alex Batchelor, Chief Executive Officer, Orbit Discovery, Els Beirnaert, Chief Executive Officer, Aelin Therapeutics, Andrew Young, Chief Scientific Officer, Intarcia Therapeutics

Registration Info


General Admission: GBP 520.00

Contact the Organizer

Organized by

Organized by LoveEvvnt1

Oxford Global

Tel: +44 1865 248455
Email: b.copeman@oxfordglobal.co.uk

Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.